Antibe Therapeutics Inc(Pre-Merger) ATBPF

Healthcare Biotechnology

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.

GREY:ATBPF - Post by User

Antibe Therapeutics Inc(Pre-Merger)

Bullboard Posts

Comment by SizzlinSteakson Mar 21, 2018 9:44am

145 Views

Post# 27752311

RE:RE:Pretty dumb move at the opening !

It is severely undervalued after yesterday's findings. Funny how everyone keeps trying to scare investors into selling. Personally, I hope it comes down....it will be a great opportunity to buy more.

Sanderz wrote:

Stevoo wrote: It a chance that phase 2 is a success. the sp should go up by now not the opposite !

You must be new to the stock market. Usually after a big run up such as yesterday, the SP goes down. Not every single time, but most times. Especially with these drug companies, it will go down and stay down for quite a long time until the next milestone. THat's what typically happens. Not sure if that will be the case with ATE, but probably will be. It's no different than the other companies as far as the stock market is concerned, no matter what the discovery is